# Hair loss on a GLP-1: how common it is per drug, and why

Source: https://pepvault.app/guides/hair-loss-on-a-glp-1

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Hair loss on a GLP-1: how common it is per drug, and why

Reviewed November 2026 16 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Hair loss on Wegovy, Zepbound and Foundayo per their labels, against placebo and by sex, why fast weight loss triggers shedding, and how long it lasts.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 16
- **Questions:** 6
- **Compounds:** 4

## The short answer

In the trials on the labels, 3 to 6% of people on Wegovy, 4 to 5% on Zepbound and 4 to 5% on Foundayo reported hair loss, against 0 to 2% on placebo, and mostly women. It is usually telogen effluvium, a temporary shed that starts around three months after fast weight loss and typically settles within six months. Protein and enough food help.

Every number checked at its primary source · Nov 20, 2026 · [16 sources](https://pepvault.app/guides/hair-loss-on-a-glp-1#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Placebo-controlled trials as summarised in the current FDA labels (Wegovy, Zepbound, Foundayo; Ozempic, Mounjaro and Saxenda list hair loss only from post-approval reports), a 2026 meta-analysis of trials, a 2026 health-records cohort in type 2 diabetes, a retrospective clinic study and reviews of telogen effluvium; the drugs' own share, apart from the weight loss, is not yet settled.

## How common is hair loss on Wegovy, Zepbound and other GLP-1s?

Uncommon, but real: on the weight-loss labels it runs a few points above placebo. Each weight-loss label counts it in the placebo-controlled trials the drug was approved on, so the rate on the drug and the rate on placebo sit side by side. The table puts the current labels together, as DailyMed prints them in November 2026.

| Label and dose | Trials the rate comes from | Hair loss on the drug | On placebo |
| --- | --- | --- | --- |
| Wegovy injection, 2.4 mg weekly | Three 68-week trials, 2,116 adults with obesity or overweight on the drug, 19% with type 2 diabetes | 3% | 1%[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) |
| Wegovy injection, 7.2 mg weekly | Two 72-week trials in adults with obesity, one in type 2 diabetes; 1,311 on 7.2 mg | 6% (3% on the 2.4 mg arm) | 1%[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) |
| Wegovy injection, 2.4 mg, ages 12 and up | One 68-week trial, 201 teenagers with obesity, 133 on the drug | 4% | 0%[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) |
| Wegovy tablets, 25 mg daily | One 64-week trial, 204 adults | No separate rate; common reactions similar to the injection's | Not given[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) |
| Zepbound, 5 / 10 / 15 mg weekly | Two 72-week trials, 2,519 adults with obesity or overweight on the drug, one in type 2 diabetes (the 5 mg rate is from the first trial only) | 5% / 4% / 5% | 1%[2](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-2) |
| Foundayo, 5.5 / 9 / 17.2 mg daily | Two 72-week trials, 3,155 adults with obesity or overweight on the drug, one in type 2 diabetes | 4% / 4% / 5% | 2%[3](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-3) |
| Ozempic (injection and tablets), Mounjaro, Saxenda | Their trial tables list no hair loss | Alopecia (hair loss) appears only in post-approval reports, with no rate | Not given[4](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-4) [5](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-5) [6](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-6) [7](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-7) |

Read each row against its own placebo dot: every label sits a few points above its placebo, and rates from different trials are not a head-to-head comparison.

The labels warn that rates from one drug's trials cannot be compared directly with another's, because the trials ran under different conditions[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1). Read across a row, drug against its own placebo, before reading down the table.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

In PepVault, the side-effect log keeps the symptom, how strong it is, the date and your own note, so the start of a shed is on record when you see your prescriber.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Why do women report hair loss on a GLP-1 more than men?

Nearly all the cases on the labels are in women. Every label splits it by sex, and the gap is wide.

| Label and pool | Women on the drug | Men on the drug | Women on placebo | Men on placebo |
| --- | --- | --- | --- | --- |
| Wegovy 2.4 mg, three weight trials | 4% | 0.9% | 2% | 0[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) |
| Wegovy 7.2 mg, two weight trials | 8.4% | 0.2% | 1.5% | 0[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) |
| Zepbound, two weight trials | 7.1% | 0.5% | 1.3% | 0%[2](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-2) |
| Foundayo, two weight trials | 7% | 0.9% | 3% | 0.7%[3](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-3) |

Look at the gap: almost every case on the labels is in women.

No label explains the gap. One clue comes from a Korean clinic's records of 140 people with shedding after weight loss: the women had lost weight more slowly than the men before the shed began, 3.1 kg a month on average against 5.0 kg[9](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-9).

Few people stopped treatment over it. No one on Zepbound stopped because of hair loss, while one person on placebo did[2](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-2). On Wegovy 7.2 mg, one case of hair loss led to stopping, one to a pause and five to a lower dose[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1).

## Why does a GLP-1 make your hair fall out?

Mostly through the weight loss itself. Wegovy's, Zepbound's and Foundayo's labels all use the same words: the hair loss was associated with weight reduction[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) [2](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-2) [3](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-3). The usual form is telogen effluvium. Each hair follicle cycles between a long growing phase (anagen) and a resting phase (telogen), after which the resting hair falls out. A shock to the body, such as surgery, a high fever, childbirth or a sudden drop in weight, pushes many follicles into rest at the same time, and those hairs shed together about two to four months later[8](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-8) [9](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-9). The hair thins all over rather than in patches.

The shed lags its trigger by about three months, which is why it can start after the weight loss is well under way.

Eating much less is the second half of the story. People on GLP-1s for weight loss eat 16 to 39% fewer calories, and the 2025 nutrition advisory from four US obesity and nutrition societies notes that below about 1,200 kcal a day for women and 1,800 for men, intakes of iron, zinc, calcium and several vitamins can fall short[14](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-14). It lists excessive hair loss among the signs of a real nutrient deficiency[14](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-14). Bariatric surgery shows both patterns: shedding within the first three months is usually telogen effluvium, while shedding that starts around six months after surgery or later is more often tied to nutrient deficiencies[15](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-15).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Cycle](https://pepvault.app/glossary/cycle)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## Is it the drug or the weight loss?

Not settled. The labels say only that the hair loss was associated with weight reduction[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) [2](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-2) [3](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-3), and a 2026 systematic review says the drugs' direct role is difficult to disentangle from the weight loss and the nutrient gaps that come with it; it asks future studies to track how much and how fast weight came off[11](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-11). A 2026 dermatology commentary adds that causality has not been established and that a direct effect of GLP-1 drugs on hair follicles has not been shown[10](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-10). The one hint of such an effect is a 2006 study that found GLP-1 receptors in the hair follicles of mouse skin; whether human follicles carry them is unknown[10](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-10).

The link itself holds up. A 2026 meta-analysis of nine studies, seven of them randomised trials, with 4,114 people on a GLP-1, put the risk of hair loss at about three times placebo's, with 3.9% of users affected[13](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-13). It shows outside the trials too: in the health records of adults with type 2 diabetes at one US health system, about 12,000 people starting a GLP-1 had a 37% higher risk of a hair-loss diagnosis than people starting an SGLT-2 inhibitor and 68% higher than those starting a DPP-4 inhibitor, two other diabetes drug classes; the authors call the absolute risk low[12](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-12).

Two findings fit the weight-loss reading. In a large US records study, people on semaglutide or tirzepatide who were diagnosed with hair loss had a lower BMI at follow-up than those who were not, which the authors read as a sign that the stress of weight loss contributes[16](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-16). And in a 2025 records study the review cites, tirzepatide, the drug with the largest and fastest weight loss among them, had a higher rate of telogen effluvium than other weight-loss medicines but one close to bariatric surgery's[11](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-11).

## When does GLP-1 hair loss start, and how long does it last?

It starts late and ends on its own. Because the shed lags its trigger, it usually shows around three months after starting the drug[10](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-10), often while the weight is still coming off. The acute form lasts less than six months; shedding that runs past six months is called chronic telogen effluvium and points to a trigger that keeps going, such as ongoing low intake[11](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-11). The 2026 commentary expects the hair loss of telogen effluvium to stop once the weight loss stops[10](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-10).

**Commonly reported:** noticing more hair in the brush, the shower drain or on the pillow somewhere around months three to five, a thinner ponytail or a wider parting, and the shedding easing once the weight levels off.

## What helps with hair shedding on a GLP-1?

Eating enough, especially protein, is what the guidance points to[10](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-10) [14](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-14). These are published recommendations, not a prescription.

1. Eat the protein part of each meal first, while your appetite lasts. The 2025 advisory lists 1.2 to 1.6 g of protein per kg of body weight a day as proposed during active weight loss[14](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-14).
2. Keep an eye on how little you eat: the advisory flags days under about 1,200 kcal for women or 1,800 for men as the range where vitamins and minerals fall short[14](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-14).
3. If your intake has been low for weeks, ask your prescriber whether to check iron, vitamin D and zinc; an uncontrolled study found low levels of all three in many people with telogen effluvium[8](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-8).
4. Skip biotin and vitamin E: the research does not support taking them for this kind of shedding[8](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-8).
5. Talk to your prescriber before changing your dose because of shedding. In the trials that report it, almost no one stopped over it[1](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-1) [2](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-2), and since the shed lags its trigger by about three months, this month's hair fall began well before[8](https://pepvault.app/guides/hair-loss-on-a-glp-1#source-8).
6. Note the date the shedding started and check it again after a few months, so you can tell whether it is easing.

<!--promo-->

In PepVault, the side-effect log keeps the symptom, how strong it is, the date and your own note, so the start of a shed is on record when you see your prescriber. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-hair-loss-on-a-glp-1-inline&mt=8)

<!--/promo-->

<!--promo-->

On Body, your weight chart and the week's change show how fast the weight is coming off, which is the pace this kind of shedding follows. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-hair-loss-on-a-glp-1-inline&mt=8)

<!--/promo-->

**When to get help** If the hair comes out in patches, the scalp is red, sore or scarred, or the shedding keeps going past about six months, see a dermatologist, since those patterns point to another kind of hair loss.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information, §6.1 (Tables 3, 4 and 5; Hair Loss). DailyMed, version 19, effective June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
2. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information, §6.1 (Table 1; Hair Loss). DailyMed, version 40, effective August 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
3. Eli Lilly and Company. FOUNDAYO (orforglipron) tablets, prescribing information, §6.1 (Table 1; Hair Loss). DailyMed, version 10, effective July 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62)
4. Novo Nordisk. OZEMPIC (semaglutide) injection, prescribing information, §6.2 Postmarketing Experience. DailyMed, version 20, effective June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
5. Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information, §6.2 Postmarketing Experience. DailyMed, version 40, effective August 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
6. Novo Nordisk. SAXENDA (liraglutide) injection, prescribing information, §6.2 Postmarketing Experience. DailyMed, version 22, effective February 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
7. Novo Nordisk. RYBELSUS and OZEMPIC (oral semaglutide) tablets, prescribing information, §6.2 Postmarketing Experience. DailyMed, version 14, effective January 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98)
8. Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019;12:583-590. [PubMed 31686886](https://pubmed.ncbi.nlm.nih.gov/31686886/)
9. Kang DH, Kwon SH, Sim WY, Lew BL. Telogen effluvium associated with weight loss: a single center retrospective study. Ann Dermatol. 2024;36(6):384-388. [PubMed 39623615](https://pubmed.ncbi.nlm.nih.gov/39623615/)
10. Piraccini BM, Vañó-Galván S, Blume-Peytavi U, et al. Hair loss in patients on glucagon-like peptide 1 receptor agonists: understanding risks and managing outcomes. Dermatol Ther (Heidelb). 2026;16(7):3345-3360. Funded by Pierre Fabre Dermo-Cosmetics. [PubMed 42249225](https://pubmed.ncbi.nlm.nih.gov/42249225/)
11. Gupta AK, Teasell EM, Economopoulos V, et al. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Sci Prog. 2026;109(2):368504261444578. [PubMed 41998799](https://pubmed.ncbi.nlm.nih.gov/41998799/)
12. Tang H, Zhang B, Lu Y, et al. Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation. BMJ. 2026;394:e100077. [PubMed 42486607](https://pubmed.ncbi.nlm.nih.gov/42486607/)
13. Cheng PL, Chang HC. Glucagon-like peptide-1 receptor agonists and hair loss: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2026;237:113333. [PubMed 42155605](https://pubmed.ncbi.nlm.nih.gov/42155605/)
14. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025;33(8):1475-1503. [PubMed 40445127](https://pubmed.ncbi.nlm.nih.gov/40445127/)
15. Cohen-Kurzrock RA, Cohen PR. Bariatric surgery-induced telogen effluvium (Bar SITE): case report and a review of hair loss following weight loss surgery. Cureus. 2021;13(4):e14617. [PubMed 34055500](https://pubmed.ncbi.nlm.nih.gov/34055500/)
16. Katragadda R, Hayden J, Saltagi AK, et al. Nonscarring alopecia in adults treated with GLP-1s: a propensity score matched TriNetX cohort study. Laryngoscope. 2026 (online Aug 26). doi:10.1002/lary.70810. [PubMed 42647098](https://pubmed.ncbi.nlm.nih.gov/42647098/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)

"Ozempic face" is the face losing fat with the body. What the trials' scans show about where GLP-1 weight comes from, and the one study that measured faces.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Orforglipron Studied range: 0.8–17.2 mg](https://pepvault.app/peptides/orforglipron)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)

  What to expect on retatrutide week by week: the trial dose steps, when appetite drops, weight loss at weeks 24, 48 and 80, and how side effects settle.

  Read the guide
- Guide · Stacks

  ### [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

  What to pair with each peptide, and why: glycine and vitamin C for repair, less zinc on GHK-Cu, fasting and sleep for GH peptides, protein on GLP-1s.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Cycle](https://pepvault.app/glossary/cycle)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
